{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:23:16Z","timestamp":1780957396668,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2017-I2M-2-001"],"award-info":[{"award-number":["2017-I2M-2-001"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.humpath.2022.05.014","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T17:32:28Z","timestamp":1653931948000},"page":"28-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Diagnostic significance of parafibromin expression in parathyroid carcinoma"],"prefix":"10.1016","volume":"127","author":[{"given":"Yike","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junliang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boju","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.05.014_bib1","first-page":"377","article-title":"Hypercalcemia and cancer: differential diagnosis and treatment","volume":"68","author":"Zagzag","year":"2018","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.humpath.2022.05.014_bib2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJMcp1714213","article-title":"Primary hyperparathyroidism","volume":"379","author":"Insogna","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2022.05.014_bib3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1210\/jc.2012-2914","article-title":"The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center","volume":"98","author":"Zhao","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2022.05.014_bib4","series-title":"WHO classification of tumours of endocrine organs","first-page":"147","article-title":"Parathyroid carcinoma","author":"DeLellis","year":"2017"},{"key":"10.1016\/j.humpath.2022.05.014_bib5","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1210\/jc.2011-1571","article-title":"Parathyroid carcinoma: a 43-year outcome and survival analysis","volume":"96","author":"Harari","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2022.05.014_bib6","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jamcollsurg.2018.03.022","article-title":"Incidental hypercalcemia and the parathyroid","volume":"226","author":"Fisher","year":"2018","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.humpath.2022.05.014_bib7","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41379-019-0252-6","article-title":"Parafibromin immunostainings of parathyroid tumors in clinical routine: a near-decade experience from a tertiary center","volume":"32","author":"Juhlin","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.05.014_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","article-title":"Parafibromin-deficient (HPT-JT type, CDC73 mutated) parathyroid tumors demonstrate distinctive morphologic features","volume":"43","author":"Gill","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.05.014_bib9","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2022.05.014_bib10","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1158\/1078-0432.CCR-04-0493","article-title":"Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma","volume":"10","author":"Tan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2022.05.014_bib11","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","article-title":"Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias","volume":"30","author":"Gill","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.05.014_bib12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1677\/ERC-07-0021","article-title":"Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification","volume":"14","author":"Juhlin","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.humpath.2022.05.014_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cncr.24037","article-title":"Defining a molecular phenotype for benign and malignant parathyroid tumors","volume":"115","author":"Fernandez-Ranvier","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2022.05.014_bib14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/jc.2008-1740","article-title":"Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma","volume":"94","author":"Howell","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2022.05.014_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13402-012-0100-x","article-title":"CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort","volume":"35","author":"Guarnieri","year":"2012","journal-title":"Cell Oncol (Dordr)"},{"key":"10.1016\/j.humpath.2022.05.014_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hed.21716","article-title":"Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma","volume":"34","author":"Kim","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.humpath.2022.05.014_bib17","first-page":"2895","article-title":"Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors","volume":"125","author":"Wang","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.humpath.2022.05.014_bib18","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00268-014-2700-2","article-title":"Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer","volume":"38","author":"Truran","year":"2014","journal-title":"World J Surg"},{"key":"10.1016\/j.humpath.2022.05.014_bib19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/PAI.0000000000000378","article-title":"Parafibromin, APC, and MIB-1 are useful markers for distinguishing parathyroid carcinomas from adenomas","volume":"25","author":"Hosny Mohammed","year":"2017","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2022.05.014_bib20","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4158\/EP-2018-0538","article-title":"The influence of surgical extent and parafibromin staining on the outcome of parathyroid carcinoma:\u00a020-YEAR experience from a single institute","volume":"25","author":"Hu","year":"2019","journal-title":"Endocr Pract"},{"key":"10.1016\/j.humpath.2022.05.014_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12022-012-9222-y","article-title":"Biomarkers of parathyroid carcinoma","volume":"23","author":"Erovic","year":"2012","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2022.05.014_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00428-010-1032-3","article-title":"Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours","volume":"459","author":"Juhlin","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2022.05.014_bib23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12022-010-9121-z","article-title":"Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas","volume":"21","author":"Juhlin","year":"2010","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2022.05.014_bib24","series-title":"AJCC cancer staging manual","first-page":"903","article-title":"Parathyroid","author":"Landry","year":"2017"},{"key":"10.1016\/j.humpath.2022.05.014_bib25","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","article-title":"Clinical practice. Primary hyperparathyroidism","volume":"365","author":"Marcocci","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2022.05.014_bib26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s12105-020-01281-6","article-title":"Distinguishing parathyromatosis, atypical parathyroid adenomas, and parathyroid carcinomas utilizing histologic and clinical features","volume":"15","author":"Schulte","year":"2021","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.humpath.2022.05.014_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-61779-055-3_3","article-title":"Standardization in immunohistology","volume":"724","author":"Leong","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.humpath.2022.05.014_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12022-013-9294-3","article-title":"Understanding the genetic basis of parathyroid carcinoma","volume":"25","author":"Gill","year":"2014","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2022.05.014_bib29","series-title":"WHO classification of tumours of endocrine organs","author":"Kl\u00f6ppel","year":"2017"},{"key":"10.1016\/j.humpath.2022.05.014_bib30","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/bjs.5974","article-title":"Letter 2: intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma (Br J Surg 2007; 94: 566-570)","volume":"94","author":"Meyer-Rochow","year":"2007","journal-title":"Br J Surg"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722001411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722001411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:39:59Z","timestamp":1758645599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722001411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":30,"alternative-id":["S0046817722001411"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.05.014","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic significance of parafibromin expression in parathyroid carcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}